New stent shows promise for tricky brain aneurysms

NCT ID NCT05254067

Completed Disease control Sponsor: Methodist Health System Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a special stent (Enterprise 2) used with coils to treat wide-neck brain aneurysms. Ten adults with this condition received the procedure. Researchers checked if the stent stayed in place, shortened, or narrowed over time. The goal was to see if this device can safely and effectively seal the aneurysm.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Codman Enterprise 2 Vascular Reconstruction Device (a stent used with coil embolization)
What this could lead to: If successful, this stent could offer a safer, more reliable way to treat wide-neck brain aneurysms, reducing the risk of coils escaping or the stent moving.
What could go wrong: This was a very small study (10 people) with no comparison group. The device may still cause complications like stent narrowing or migration, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Aneurysm brain aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANEURYSM

Contacts and locations

Locations

Moody Brain and Spine Institute at Methodist Dallas Medical Center

Dallas, Texas, 75203, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.